Skip to main content

Anjelica Gonzalez

Anjelica Gonzalez currently serves as Associate Professor of Biomedical Engineering and part of the Vascular Biology and Therapeutics Program. Her research has focused on the development of biomimetic materials for use in investigation of immunology, inflammation and fibrosis.

Gonzalez has a dedicated interest in training the next generation of scientists to think in an interdisciplinary way and approach problems from a scientifically global perspective. With a multi-disciplinary approach, the Gonzalez Lab combines organic chemistry, molecular biology, mathematics, computational modeling and image analysis to develop and use engineered scaffolds to dissect the chemo-mechanics of immunological processes. This work has led to significant advancement specific to an array of diseases and disorders, including vascular inflammation, stroke, fibrosis, and sepsis.

Gonzalez’s translational research interests have led to the development of new technologies that are being deployed in underserved and low-infrastructures settings across the world. PremieBreathe, a low-cost, mobile neonatal respiratory device invented by Anjelica, has been supported by the US Agency for International Development (USAID), Bill and Melinda Gates Foundation and NCIIA/Venturewell for development and study deployment in Ethiopia.

Within Yale, Anjelica has been recognized for her dedication to exceptional teaching, having been awarded the Provost’s Teaching Award, the top prize awarded for teaching across all of Yale University, including Yale College, Yale School of Medicine, School of Management, and Yale Law School. Her efforts in education and public inclusion in science is noted by her opinion pieces published in Science and the New York Times.

To date, Anjelica’s research and social efforts have been acknowledged by national organizations, including the National Institutes of Health, NBC, Biomedical Engineering Society, Microcirculation Society, American Society for Investigative Pathology, the American Physiological Society and The Hartwell Foundation.